Discussing RA: Malignancy risk in patients with RA and the evolution of JAKi prescriptions
The IMID Forum
- Published
- March 26, 2026
- Duration
- 10:02
- Summary source
- description
- Last updated
- Aug 5, 2026
Discusses Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammat…
Summary
Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review a paper a paper on the malignancy risk in patients with RA initiating b/tsDMARDS, and the evolution of JAKi prescriptions since 2015 in an international collaboration of rheumatoid arthritis registers.
Intelligent Report
Sign in to read teasers, or upgrade to Research Pro to commission intelligent report for this episode. Learn more →
Show notes
Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review a paper a paper on the malignancy risk in patients with RA initiating b/tsDMARDS, and the evolution of JAKi prescriptions since 2015 in an international collaboration of rheumatoid arthritis registers.